All articles
Cancer Genetics· 2 min read

Germline vs Somatic Testing: Two Different Cancer Questions

Germline testing looks for inherited variants in normal DNA; somatic testing examines changes in tumour cells. The same gene can appear on both reports, but the result may answer a different question.

BRCA1BRCA2TP53ATM

Quick Answer

Germline testing looks for inherited variants in normal DNA; somatic testing examines changes in tumour cells. The same gene can appear on both reports, but the result may answer a different question.

Germline vs Somatic Testing: Two Different Cancer Questions: mechanism and interpretation mapThree connected stages summarise the article's mechanism, measured effect and interpretation boundary.BRCA1 · BRCA2 · TP53 · ATM1What Each Sample RepresentsMechanism2When Results OverlapObserved consequence3Key TakeawaysInterpret in contextGene or pathway evidence → measured phenotype → assay-aware conclusion
Mechanism map: the article’s main biological stages are separated from the final interpretation so a pathway relationship is not mistaken for a clinical conclusion.

What Each Sample Represents

Blood or saliva is commonly used for germline testing because it represents inherited DNA. Tumour sequencing examines cancer cells and may reveal changes acquired during tumour development.

When Results Overlap

A tumour result in a hereditary-cancer gene may prompt consideration of germline follow-up, but it cannot independently prove inheritance. Testing consent and counselling remain important.

Key Takeaways

  • ·Germline testing addresses inherited predisposition.
  • ·Somatic testing describes the tumour.
  • ·The same gene name does not make the results interchangeable.

Put these genes in pathway context

DNA-damage response Homologous recombination repair Cell-cycle regulation

Frequently asked questions

What is the key idea in Germline vs Somatic Testing: Two Different Cancer Questions?

Germline testing looks for inherited variants in normal DNA; somatic testing examines changes in tumour cells. The same gene can appear on both reports, but the result may answer a different question.

What should be kept with the result or mechanism?

Germline testing addresses inherited predisposition. Somatic testing describes the tumour. The same gene name does not make the results interchangeable.

References

  1. 1Cancer genetics overview. National Cancer Institute, 2026. Source
  2. 2BRCA fact sheet. National Cancer Institute, 2026. Source
  3. 3Molecular testing guideline for lung cancer. Journal of Thoracic Oncology, 2018. PubMed

Continue Reading

Variant of Uncertain Significance: How to Read a VUS Result

2 min read

BAP1 Tumour Predisposition Syndrome

3 min read

DNMT3A and TET2 in Clonal Haematopoiesis

3 min read

BRCA1: Homologous Recombination, Inherited Risk and HRD

7 min read

Homologous Recombination Deficiency: BRCA, ATM and HRD Testing

6 min read

TP53 and Li-Fraumeni Syndrome: Inherited-Risk Context

3 min read

Choose your next research step

Move from this explanation into a gene profile, a pathway map, or the next evidence update.

Explore BRCA1Open pathway contextTrack BRCA1 trials

BRCA1 has 100+ trials currently recruiting on ClinicalTrials.gov. The GeneAnalyses digest summarises the new and changed ones each day.

Clinical Trials News

A daily, plain-language digest of new oncology and life-sciences clinical trials, with a weekly deep-dive roundup — every update linked to its trial registry or primary source.